Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Hemangiosarcoma 1

Interventions

pazopanib 2 Ifosfamide 2 Doxorubicin 2 selinexor 1 carotuximab 1 Sunitinib 1 Proton Therapy 1 Propranolol 1 Nivolumab 1 Methotrexate 1 Imatinib Mesylate 1 HhAntag691 1 Epirubicin 1 Dacarbazine 1 Cisplatin 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hemangiosarcoma × Propranolol × Clear all

NCT02732678 2016-04-11

PROPAN

Assistance Publique Hopitaux De Marseille

Phase 1/2 Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡